NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Capital Medical University
Sun Yat-sen University
The First Hospital of Jilin University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sykehuset i Vestfold HF
Shanghai University of Traditional Chinese Medicine